APA (7th ed.) Citation

Megna, M., Ruggiero, A., Ferrillo, M., & Fabbrocini, G. (2020). QuantiFERON‐TB Gold conversion is not uncommon in patients with psoriasis undergoing anti‐tumour necrosis factor‐α therapy. British Journal of Dermatology, 183(5), 977. https://doi.org/10.1111/bjd.19310

Chicago Style (17th ed.) Citation

Megna, M., A. Ruggiero, M. Ferrillo, and G. Fabbrocini. "QuantiFERON‐TB Gold Conversion Is Not Uncommon in Patients with Psoriasis Undergoing Anti‐tumour Necrosis Factor‐α Therapy." British Journal of Dermatology 183, no. 5 (2020): 977. https://doi.org/10.1111/bjd.19310.

MLA (9th ed.) Citation

Megna, M., et al. "QuantiFERON‐TB Gold Conversion Is Not Uncommon in Patients with Psoriasis Undergoing Anti‐tumour Necrosis Factor‐α Therapy." British Journal of Dermatology, vol. 183, no. 5, 2020, p. 977, https://doi.org/10.1111/bjd.19310.